
Gimv hires DACH life sciences partner
Gimv has hired Annegret de Baey-Diepolder as a partner to join the firm’s life sciences in the DACH region; she will be base in Munich.
De Baey-Diepolder started her career as a doctor at the dermatology and allergology university clinic in Munich. During her post-doctoral studies, she worked at the Hoffmann La Roche institute for immonology. In 2001 she became an associate at TVM Capital, becoming a partner at the venture firm in five years later.
During her career at TVM she was involved in the transactions regarding Jerini, Intercell, Medigene PIPE and Riemser Arzneimittel AG, while she also sat on the board of Vivendy, Albireo Pharma and Nitec.
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote
Permira to take Ergomed private for GBP 703m
Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO
Partners Group to release IMs for Civica sale in mid-September
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Change of mind: Sponsors take to de-listing their own assets
EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater